Literature DB >> 24126972

Effects of modified Sanhuang decoction () enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats.

Shuai Wang1, Tao Zhou, Jun-Peng Zhai, Li-Hua Wang, Jing Chen.   

Abstract

OBJECTIVE: To investigate the effects of Modified Sanhuang Decoction (, MSD) enema on the serum tumor necrosis factor alpha (TNF-α) and colonic mucosa interleukin-1β (IL-1β), interleukin-6 (IL-6) levels in experimental ulcerative colitis (UC) rats.
METHODS: Forty-five male Wistar rats were randomly divided into 4 groups: normal group (n=12), model group (n=11), salazosulfapyridine (SASP) group (n=11) and MSD group (n=11). The UC model was induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol solution. Rats in the normal group and model group were clystered with 0.9% normal saline, while in the SASP group and MSD group were clystered with SASP and MSD enema, respectively. After drug administration (10 mL/kg body weight, for 7 days), colonic gross changes and colonic mucosa histology were observed, serum TNF-α and colonic mucosa IL-1β, IL-6 levels were tested by enzyme linked immunosorbent assay and radioimmunoassay, respectively.
RESULTS: As compared with the normal group, the experimental UC rats, the colonic mucosal damage index scores (CMDIs), histopathological scores (HS) and the serum TNF-α and colonic mucosa IL-1β, IL-6 levels significantly increased (P<0.05 or P<0.01). In the MSD and SASP groups, the ulcer area significantly reduced, and edema disappeared. The CMDIs, HS, the serum TNF-α and colonic mucosa IL-1β, IL-6 levels in the MSD and SASP groups significantly decreased (P<0.05 or P<0.01) compared with the model group. The CMDIs in the MSD group were lower than that in the SASP group (P<0.05), but there were no significant differences in HS, serum TNF-α or colonic mucosa IL-1β, IL-6 levels between the MSD and SASP groups.
CONCLUSION: MSD enema can improve colonic mucosa impairment and decrease serum TNF-α and colonic mucosa IL-1β, IL-6 levels in experimental UC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126972     DOI: 10.1007/s11655-013-1538-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  20 in total

1.  Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.

Authors:  Gülsüm E Pamuk; Ozden Vural; Burhan Turgut; Muzaffer Demir; Hasan Umit; Ahmet Tezel
Journal:  Am J Hematol       Date:  2006-10       Impact factor: 10.047

Review 2.  Microbial influences in inflammatory bowel diseases.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2008-02       Impact factor: 22.682

3.  Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo.

Authors:  Chang-Duk Jun; Yurim Kim; Eun-Yong Choi; Minsun Kim; Byungrim Park; Byungsoo Youn; Kangyeol Yu; Kyu-Sil Choi; Kwon-Ha Yoon; Suck-Chei Choi; Myeung-Su Lee; Kie-In Park; Minkyu Choi; Yeuntai Chung; Jaemin Oh
Journal:  Inflamm Bowel Dis       Date:  2006-07       Impact factor: 5.325

4.  Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group.

Authors:  J R Little; H N Eisen
Journal:  Biochemistry       Date:  1966-11       Impact factor: 3.162

Review 5.  The Asia-Pacific consensus on ulcerative colitis.

Authors:  Choon Jin Ooi; Kwong Ming Fock; Govind K Makharia; Khean Lee Goh; Khoon Lin Ling; Ida Hilmi; Wee Chian Lim; Thia Kelvin; Peter R Gibson; Richard B Gearry; Qin Ouyang; Jose Sollano; Sathaporn Manatsathit; Rungsun Rerknimitr; Shu-Chen Wei; Wai Keung Leung; H Janaka de Silva; Rupert Wl Leong
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

6.  Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (colitis ulcerosa).

Authors:  Beata Polińska; Joanna Matowicka-Karna; Halina Kemona
Journal:  Folia Histochem Cytobiol       Date:  2011       Impact factor: 1.698

7.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

Authors:  I I Singer; D W Kawka; S Schloemann; T Tessner; T Riehl; W F Stenson
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

9.  Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.

Authors:  V Casini-Raggi; L Kam; Y J Chong; C Fiocchi; T T Pizarro; F Cominelli
Journal:  J Immunol       Date:  1995-03-01       Impact factor: 5.422

10.  High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD.

Authors:  Alberto J León; Emma Gómez; Jose A Garrote; David Bernardo; Asterio Barrera; Jose L Marcos; Luis Fernández-Salazar; Benito Velayos; Alfredo Blanco-Quirós; Eduardo Arranz
Journal:  Mediators Inflamm       Date:  2009-07-30       Impact factor: 4.711

View more
  4 in total

1.  Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway.

Authors:  Xiao-Qing Zhang; Chang Yao; Wei-He Bian; Xu Chen; Jing-Xian Xue; Zhi-Yuan Zhu; Yu Ying; Yan Lei Xu; Cong Wang
Journal:  Food Sci Nutr       Date:  2019-09-18       Impact factor: 2.863

2.  Jiaweishaoyao Decoction Alleviates DSS-Induced Ulcerative Colitis via Inhibiting Inflammation.

Authors:  Huixia Qiao; Yahui Huang; Xiaoyan Chen; Long Yang; Yue Wang; Rongrong Xu
Journal:  Gastroenterol Res Pract       Date:  2020-05-27       Impact factor: 2.260

3.  Protective effects of growth hormone-releasing hormone analogs in DSS-induced colitis in mice.

Authors:  Lucia Recinella; Annalisa Chiavaroli; Valentina Di Valerio; Serena Veschi; Giustino Orlando; Claudio Ferrante; Iacopo Gesmundo; Riccarda Granata; Renzhi Cai; Wei Sha; Andrew V Schally; Rossano Lattanzio; Luigi Brunetti; Sheila Leone
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

4.  Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis.

Authors:  Jan Sommer; Erika Engelowski; Paul Baran; Christoph Garbers; Doreen M Floss; Jürgen Scheller
Journal:  Int J Mol Med       Date:  2014-06-27       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.